Dr. Akerman and his team were recently featured for their groundbreaking work in blood-based detection of aortic aneurysms, a condition that can silently weaken the body’s largest artery and become fatal. Traditional detection relies on CT scans, which are costly and expose patients to ionizing radiation.
Akerman’s team has developed a novel approach that combines blood analysis of molecular markers with AI-driven imaging data to predict aneurysm presence and even reconstruct the aorta from a single blood sample. This method is faster, less invasive, and adaptable to diverse patient populations, including those historically underserved or at higher risk due to genetic conditions.
Read the full article: Blood-based screening for aneurysms and access the Technology.
The Akerman laboratory group welcomes collaboration with the UNC community and external partners to scale and test this technology. Those interested in learning more or participating in trials can contact Dr. Adam Akerman directly at: adam_akerman@med.unc.edu